Go Pro
NASDAQ:MOTS

Motus GI (MOTS) Stock Price, News & Analysis

Motus GI logo
$0.0002 +0.00 (+100.00%)
As of 09/23/2026 03:25 PM Eastern

About Motus GI Stock (NASDAQ:MOTS)

Advanced

Key Stats

Today's Range
$0.0001
$0.0002
50-Day Range
N/A
52-Week Range
$0.00
$0.10
Volume
11,087 shs
Average Volume
6,550 shs
Market Capitalization
$1.15 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Motus GI Holdings, Inc. (NASDAQ:MOTS) is a medical technology company focused on developing and commercializing solutions for gastrointestinal procedures. Its primary product is the Pure-Vu system, an endoscopic visualization platform designed to help physicians improve visualization during colonoscopy when residual stool or other material obstructs the view.

The Pure-Vu system is designed to work with a standard colonoscope and uses integrated irrigation and suction to remove debris during the procedure. The platform includes a specialized disposable sleeve and is intended to help address inadequate bowel preparation, which can limit the effectiveness of colonoscopy and sometimes require repeat procedures.

Motus GI has focused its commercialization and clinical activities primarily on the United States and Europe. The company was established to develop technologies aimed at improving the efficiency and effectiveness of gastrointestinal endoscopy, with its Pure-Vu platform representing its principal commercial product and area of business.

AI Generated. May Contain Errors.

Receive MOTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Motus GI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MOTS Stock News Headlines

MOTS Motus GI Holdings, Inc. - Seeking Alpha
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
See More Headlines

MOTS Stock Analysis - Frequently Asked Questions

Motus GI's stock was trading at $0.0001 at the beginning of 2026. Since then, MOTS stock has increased by 100.0% and is now trading at $0.0002.

Motus GI Holdings, Inc. (NASDAQ:MOTS) announced its quarterly earnings results on Friday, November, 12th. The company reported ($30.00) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($30.00). The company had revenue of $0.14 million for the quarter, compared to analysts' expectations of $0.12 million.

Motus GI shares reverse split before market open on Thursday, November 2nd 2023.The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Motus GI (MOTS) raised $21 million in an initial public offering (IPO) on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

Shares of MOTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Motus GI investors own include Inovio Pharmaceuticals (INO), Matinas Biopharma (MTNB), NIO (NIO), Tesla (TSLA), Bionano Genomics (BNGO), Pfizer (PFE).

Company Calendar

Last Earnings
11/12/2021
Today
9/23/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:MOTS
CIK
1686850
Employees
15
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$319 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
5,769,000
Free Float
5,749,000
Market Cap
$1.15 thousand
Optionable
Not Optionable
Beta
0.81

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:MOTS) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners